nodes	percent_of_prediction	percent_of_DWPC	metapath
Molindone—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0918	0.177	CbGeAlD
Molindone—HTR7—vagus nerve—peripheral nervous system neoplasm	0.0503	0.0973	CbGeAlD
Molindone—HTR7—cranial nerve—peripheral nervous system neoplasm	0.0383	0.0741	CbGeAlD
Molindone—HTR7—pons—peripheral nervous system neoplasm	0.0379	0.0732	CbGeAlD
Molindone—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.0336	0.0648	CbGeAlD
Molindone—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.0314	0.0606	CbGeAlD
Molindone—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.0239	0.0462	CbGeAlD
Molindone—HTR2A—pons—peripheral nervous system neoplasm	0.0236	0.0457	CbGeAlD
Molindone—HTR1A—ganglion—peripheral nervous system neoplasm	0.0203	0.0392	CbGeAlD
Molindone—HTR7—nerve—peripheral nervous system neoplasm	0.0197	0.038	CbGeAlD
Molindone—HTR7—ganglion—peripheral nervous system neoplasm	0.0194	0.0375	CbGeAlD
Molindone—DRD2—nerve—peripheral nervous system neoplasm	0.0186	0.0359	CbGeAlD
Molindone—DRD2—ganglion—peripheral nervous system neoplasm	0.0183	0.0355	CbGeAlD
Molindone—Pigmentation disorder—Etoposide—peripheral nervous system neoplasm	0.0177	0.0374	CcSEcCtD
Molindone—HTR2A—nerve—peripheral nervous system neoplasm	0.0123	0.0237	CbGeAlD
Molindone—HTR2A—ganglion—peripheral nervous system neoplasm	0.0121	0.0234	CbGeAlD
Molindone—Throat tightness—Etoposide—peripheral nervous system neoplasm	0.012	0.0255	CcSEcCtD
Molindone—Amenorrhoea—Melphalan—peripheral nervous system neoplasm	0.0112	0.0237	CcSEcCtD
Molindone—Leukocytosis—Tretinoin—peripheral nervous system neoplasm	0.0106	0.0225	CcSEcCtD
Molindone—Leukocytosis—Isotretinoin—peripheral nervous system neoplasm	0.0106	0.0225	CcSEcCtD
Molindone—CHRM1—parotid gland—peripheral nervous system neoplasm	0.0106	0.0204	CbGeAlD
Molindone—Pigmentation disorder—Epirubicin—peripheral nervous system neoplasm	0.00992	0.021	CcSEcCtD
Molindone—Pigmentation disorder—Doxorubicin—peripheral nervous system neoplasm	0.00918	0.0194	CcSEcCtD
Molindone—HTR1A—brainstem—peripheral nervous system neoplasm	0.00883	0.0171	CbGeAlD
Molindone—Euphoric mood—Tretinoin—peripheral nervous system neoplasm	0.00858	0.0182	CcSEcCtD
Molindone—Euphoric mood—Isotretinoin—peripheral nervous system neoplasm	0.00858	0.0182	CcSEcCtD
Molindone—HTR7—brainstem—peripheral nervous system neoplasm	0.00844	0.0163	CbGeAlD
Molindone—Leukocytosis—Alitretinoin—peripheral nervous system neoplasm	0.00805	0.017	CcSEcCtD
Molindone—DRD2—brainstem—peripheral nervous system neoplasm	0.00798	0.0154	CbGeAlD
Molindone—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00699	0.0135	CbGeAlD
Molindone—Euphoric mood—Alitretinoin—peripheral nervous system neoplasm	0.0065	0.0138	CcSEcCtD
Molindone—Dysphagia—Isotretinoin—peripheral nervous system neoplasm	0.00627	0.0133	CcSEcCtD
Molindone—Dysphagia—Tretinoin—peripheral nervous system neoplasm	0.00627	0.0133	CcSEcCtD
Molindone—Weight increased—Topotecan—peripheral nervous system neoplasm	0.00575	0.0122	CcSEcCtD
Molindone—Weight increased—Tretinoin—peripheral nervous system neoplasm	0.0057	0.0121	CcSEcCtD
Molindone—Weight increased—Isotretinoin—peripheral nervous system neoplasm	0.0057	0.0121	CcSEcCtD
Molindone—Weight decreased—Tretinoin—peripheral nervous system neoplasm	0.00567	0.012	CcSEcCtD
Molindone—Weight decreased—Isotretinoin—peripheral nervous system neoplasm	0.00567	0.012	CcSEcCtD
Molindone—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.00559	0.0118	CcSEcCtD
Molindone—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.00559	0.0118	CcSEcCtD
Molindone—HTR2A—brainstem—peripheral nervous system neoplasm	0.00526	0.0102	CbGeAlD
Molindone—Dysphagia—Dactinomycin—peripheral nervous system neoplasm	0.00512	0.0108	CcSEcCtD
Molindone—Urinary retention—Vincristine—peripheral nervous system neoplasm	0.00503	0.0107	CcSEcCtD
Molindone—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.00475	0.01	CcSEcCtD
Molindone—HTR1A—cerebellum—peripheral nervous system neoplasm	0.00435	0.00841	CbGeAlD
Molindone—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.00432	0.00914	CcSEcCtD
Molindone—Weight decreased—Alitretinoin—peripheral nervous system neoplasm	0.0043	0.00909	CcSEcCtD
Molindone—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00423	0.00896	CcSEcCtD
Molindone—Muscle spasms—Topotecan—peripheral nervous system neoplasm	0.00423	0.00895	CcSEcCtD
Molindone—HTR7—cerebellum—peripheral nervous system neoplasm	0.00416	0.00804	CbGeAlD
Molindone—Weight decreased—Vincristine—peripheral nervous system neoplasm	0.00414	0.00876	CcSEcCtD
Molindone—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00411	0.00871	CcSEcCtD
Molindone—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00411	0.00871	CcSEcCtD
Molindone—Tremor—Isotretinoin—peripheral nervous system neoplasm	0.00409	0.00865	CcSEcCtD
Molindone—Tremor—Tretinoin—peripheral nervous system neoplasm	0.00409	0.00865	CcSEcCtD
Molindone—Agitation—Tretinoin—peripheral nervous system neoplasm	0.00401	0.00849	CcSEcCtD
Molindone—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.00401	0.00849	CcSEcCtD
Molindone—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00394	0.00833	CcSEcCtD
Molindone—DRD2—cerebellum—peripheral nervous system neoplasm	0.00393	0.0076	CbGeAlD
Molindone—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00386	0.00816	CcSEcCtD
Molindone—Amenorrhoea—Epirubicin—peripheral nervous system neoplasm	0.00377	0.00797	CcSEcCtD
Molindone—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.00371	0.00784	CcSEcCtD
Molindone—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00364	0.00769	CcSEcCtD
Molindone—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00364	0.00769	CcSEcCtD
Molindone—Dyskinesia—Epirubicin—peripheral nervous system neoplasm	0.00352	0.00746	CcSEcCtD
Molindone—Amenorrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00349	0.00738	CcSEcCtD
Molindone—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00348	0.00736	CcSEcCtD
Molindone—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00348	0.00736	CcSEcCtD
Molindone—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00343	0.00726	CcSEcCtD
Molindone—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00333	0.00704	CcSEcCtD
Molindone—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00333	0.00704	CcSEcCtD
Molindone—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00329	0.00695	CcSEcCtD
Molindone—Dyskinesia—Doxorubicin—peripheral nervous system neoplasm	0.00326	0.0069	CcSEcCtD
Molindone—Salivary hypersecretion—Epirubicin—peripheral nervous system neoplasm	0.00322	0.0068	CcSEcCtD
Molindone—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.0032	0.00678	CcSEcCtD
Molindone—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00319	0.00676	CcSEcCtD
Molindone—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00318	0.00672	CcSEcCtD
Molindone—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00318	0.00672	CcSEcCtD
Molindone—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00317	0.0067	CcSEcCtD
Molindone—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00317	0.0067	CcSEcCtD
Molindone—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00314	0.00663	CcSEcCtD
Molindone—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.0066	CcSEcCtD
Molindone—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.0031	0.00656	CcSEcCtD
Molindone—Constipation—Topotecan—peripheral nervous system neoplasm	0.00307	0.0065	CcSEcCtD
Molindone—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.00305	0.00589	CbGeAlD
Molindone—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00305	0.00645	CcSEcCtD
Molindone—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00305	0.00645	CcSEcCtD
Molindone—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00643	CcSEcCtD
Molindone—Salivary hypersecretion—Doxorubicin—peripheral nervous system neoplasm	0.00298	0.0063	CcSEcCtD
Molindone—Agitation—Vincristine—peripheral nervous system neoplasm	0.00293	0.0062	CcSEcCtD
Molindone—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00285	0.00604	CcSEcCtD
Molindone—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00276	0.00583	CcSEcCtD
Molindone—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00271	0.00573	CcSEcCtD
Molindone—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00266	0.00562	CcSEcCtD
Molindone—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00264	0.00559	CcSEcCtD
Molindone—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00264	0.00558	CcSEcCtD
Molindone—HTR2A—cerebellum—peripheral nervous system neoplasm	0.00259	0.00501	CbGeAlD
Molindone—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00252	0.00534	CcSEcCtD
Molindone—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00252	0.00534	CcSEcCtD
Molindone—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00248	0.00525	CcSEcCtD
Molindone—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00243	0.00514	CcSEcCtD
Molindone—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00241	0.00509	CcSEcCtD
Molindone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.0024	0.00508	CcSEcCtD
Molindone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00231	0.00489	CcSEcCtD
Molindone—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00231	0.00489	CcSEcCtD
Molindone—Rash—Topotecan—peripheral nervous system neoplasm	0.00226	0.00479	CcSEcCtD
Molindone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00226	0.00479	CcSEcCtD
Molindone—Rash—Tretinoin—peripheral nervous system neoplasm	0.00225	0.00475	CcSEcCtD
Molindone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00225	0.00475	CcSEcCtD
Molindone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00225	0.00475	CcSEcCtD
Molindone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00224	0.00475	CcSEcCtD
Molindone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00224	0.00475	CcSEcCtD
Molindone—Constipation—Vincristine—peripheral nervous system neoplasm	0.00223	0.00471	CcSEcCtD
Molindone—Rash—Melphalan—peripheral nervous system neoplasm	0.00222	0.00469	CcSEcCtD
Molindone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00222	0.00469	CcSEcCtD
Molindone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00215	0.00455	CcSEcCtD
Molindone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00213	0.00451	CcSEcCtD
Molindone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00212	0.00448	CcSEcCtD
Molindone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00212	0.00448	CcSEcCtD
Molindone—Nausea—Melphalan—peripheral nervous system neoplasm	0.00209	0.00442	CcSEcCtD
Molindone—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00208	0.0044	CcSEcCtD
Molindone—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00206	0.00435	CcSEcCtD
Molindone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00205	0.00434	CcSEcCtD
Molindone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00197	0.00417	CcSEcCtD
Molindone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.00407	CcSEcCtD
Molindone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00189	0.004	CcSEcCtD
Molindone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00398	CcSEcCtD
Molindone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00188	0.00398	CcSEcCtD
Molindone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00187	0.00396	CcSEcCtD
Molindone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00392	CcSEcCtD
Molindone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00184	0.00389	CcSEcCtD
Molindone—Constipation—Etoposide—peripheral nervous system neoplasm	0.0018	0.00381	CcSEcCtD
Molindone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.0037	CcSEcCtD
Molindone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00368	CcSEcCtD
Molindone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00173	0.00366	CcSEcCtD
Molindone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00363	CcSEcCtD
Molindone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.0036	CcSEcCtD
Molindone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.0036	CcSEcCtD
Molindone—Rash—Vincristine—peripheral nervous system neoplasm	0.00164	0.00347	CcSEcCtD
Molindone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00164	0.00347	CcSEcCtD
Molindone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0016	0.00339	CcSEcCtD
Molindone—Nausea—Vincristine—peripheral nervous system neoplasm	0.00155	0.00327	CcSEcCtD
Molindone—Rash—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00307	CcSEcCtD
Molindone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00307	CcSEcCtD
Molindone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00294	CcSEcCtD
Molindone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00137	0.00289	CcSEcCtD
Molindone—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00136	0.00289	CcSEcCtD
Molindone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00281	CcSEcCtD
Molindone—Rash—Etoposide—peripheral nervous system neoplasm	0.00133	0.00281	CcSEcCtD
Molindone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00133	0.00281	CcSEcCtD
Molindone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.0013	0.00274	CcSEcCtD
Molindone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.00129	0.00272	CcSEcCtD
Molindone—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00267	CcSEcCtD
Molindone—Nausea—Etoposide—peripheral nervous system neoplasm	0.00125	0.00265	CcSEcCtD
Molindone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.0026	CcSEcCtD
Molindone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00255	CcSEcCtD
Molindone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00254	CcSEcCtD
Molindone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00244	CcSEcCtD
Molindone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00236	CcSEcCtD
Molindone—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00234	CcSEcCtD
Molindone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00226	CcSEcCtD
Molindone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00223	CcSEcCtD
Molindone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00105	0.00222	CcSEcCtD
Molindone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00216	CcSEcCtD
Molindone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00214	CcSEcCtD
Molindone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000975	0.00206	CcSEcCtD
Molindone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000972	0.00206	CcSEcCtD
Molindone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000935	0.00198	CcSEcCtD
Molindone—Rash—Epirubicin—peripheral nervous system neoplasm	0.000745	0.00158	CcSEcCtD
Molindone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000744	0.00157	CcSEcCtD
Molindone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000702	0.00148	CcSEcCtD
Molindone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.00146	CcSEcCtD
Molindone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000689	0.00146	CcSEcCtD
Molindone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000649	0.00137	CcSEcCtD
Molindone—ADRA2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	4.75e-05	0.00487	CbGpPWpGaD
Molindone—HTR1A—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	4.68e-05	0.0048	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	4.44e-05	0.00455	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—NTS—peripheral nervous system neoplasm	4.37e-05	0.00448	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	4.34e-05	0.00445	CbGpPWpGaD
Molindone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	4.34e-05	0.00445	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	4.32e-05	0.00442	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—CD55—peripheral nervous system neoplasm	4.19e-05	0.00429	CbGpPWpGaD
Molindone—DRD2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	4.11e-05	0.00421	CbGpPWpGaD
Molindone—HTR1A—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	4.09e-05	0.00419	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.86e-05	0.00396	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.82e-05	0.00392	CbGpPWpGaD
Molindone—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—peripheral nervous system neoplasm	3.81e-05	0.0039	CbGpPWpGaD
Molindone—HTR1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.72e-05	0.00381	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.68e-05	0.00377	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	3.68e-05	0.00377	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.64e-05	0.00373	CbGpPWpGaD
Molindone—DRD2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	3.59e-05	0.00368	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.56e-05	0.00365	CbGpPWpGaD
Molindone—HTR7—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	3.34e-05	0.00343	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—VIP—peripheral nervous system neoplasm	3.31e-05	0.00339	CbGpPWpGaD
Molindone—DRD2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.27e-05	0.00335	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.24e-05	0.00332	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	3.22e-05	0.0033	CbGpPWpGaD
Molindone—ADRA2A—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	3.22e-05	0.0033	CbGpPWpGaD
Molindone—HTR2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.21e-05	0.00329	CbGpPWpGaD
Molindone—CHRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	3.2e-05	0.00328	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.13e-05	0.00321	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.1e-05	0.00318	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.08e-05	0.00315	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.06e-05	0.00314	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.05e-05	0.00313	CbGpPWpGaD
Molindone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	2.92e-05	0.003	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	2.84e-05	0.00291	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.83e-05	0.0029	CbGpPWpGaD
Molindone—HTR1A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.83e-05	0.0029	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	2.8e-05	0.00287	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	2.8e-05	0.00287	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	2.78e-05	0.00285	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	2.72e-05	0.00279	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.7e-05	0.00277	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	2.68e-05	0.00275	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	2.67e-05	0.00273	CbGpPWpGaD
Molindone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	2.64e-05	0.0027	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	2.62e-05	0.00269	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.58e-05	0.00264	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	2.54e-05	0.00261	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.49e-05	0.00255	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.49e-05	0.00255	CbGpPWpGaD
Molindone—HTR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.48e-05	0.00254	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.47e-05	0.00253	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.45e-05	0.00251	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.45e-05	0.00251	CbGpPWpGaD
Molindone—HTR2A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	2.45e-05	0.00251	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	2.44e-05	0.0025	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.43e-05	0.0025	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.37e-05	0.00243	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.33e-05	0.00239	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.32e-05	0.00238	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.26e-05	0.00232	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	2.23e-05	0.00228	CbGpPWpGaD
Molindone—DRD2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.18e-05	0.00223	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.16e-05	0.00221	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.15e-05	0.00221	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.15e-05	0.0022	CbGpPWpGaD
Molindone—HTR2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.14e-05	0.00219	CbGpPWpGaD
Molindone—CHRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.13e-05	0.00218	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	2.12e-05	0.00218	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.12e-05	0.00217	CbGpPWpGaD
Molindone—CHRM1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	2.12e-05	0.00217	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.11e-05	0.00216	CbGpPWpGaD
Molindone—HTR7—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	2e-05	0.00205	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—KNG1—peripheral nervous system neoplasm	1.99e-05	0.00204	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.99e-05	0.00204	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.96e-05	0.00201	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.96e-05	0.002	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.96e-05	0.002	CbGpPWpGaD
Molindone—ADRA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	1.95e-05	0.002	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.94e-05	0.00199	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	1.93e-05	0.00198	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.91e-05	0.00196	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.89e-05	0.00194	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.83e-05	0.00188	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.8e-05	0.00185	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—GNS—peripheral nervous system neoplasm	1.8e-05	0.00184	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	1.78e-05	0.00182	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—GNAS—peripheral nervous system neoplasm	1.74e-05	0.00178	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—NME1—peripheral nervous system neoplasm	1.72e-05	0.00177	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.72e-05	0.00176	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.68e-05	0.00172	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—HGF—peripheral nervous system neoplasm	1.66e-05	0.0017	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—COX2—peripheral nervous system neoplasm	1.66e-05	0.0017	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.65e-05	0.00169	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.64e-05	0.00168	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.61e-05	0.00165	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.6e-05	0.00164	CbGpPWpGaD
Molindone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.59e-05	0.00163	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.58e-05	0.00162	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.58e-05	0.00162	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.57e-05	0.00161	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.5e-05	0.00154	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.45e-05	0.00149	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.45e-05	0.00148	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.44e-05	0.00148	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.41e-05	0.00144	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.4e-05	0.00143	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.38e-05	0.00142	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.38e-05	0.00141	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.36e-05	0.00139	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.34e-05	0.00137	CbGpPWpGaD
Molindone—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.3e-05	0.00133	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.28e-05	0.00131	CbGpPWpGaD
Molindone—CHRM1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	1.27e-05	0.00131	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.27e-05	0.0013	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.27e-05	0.0013	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.26e-05	0.00129	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.26e-05	0.00129	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.25e-05	0.00128	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.25e-05	0.00128	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.24e-05	0.00128	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.23e-05	0.00126	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.21e-05	0.00124	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.21e-05	0.00124	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.2e-05	0.00123	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.19e-05	0.00122	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.17e-05	0.0012	CbGpPWpGaD
Molindone—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.16e-05	0.00119	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.16e-05	0.00119	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.16e-05	0.00118	CbGpPWpGaD
Molindone—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.15e-05	0.00118	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.15e-05	0.00118	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.14e-05	0.00117	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.14e-05	0.00117	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.12e-05	0.00114	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.1e-05	0.00113	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.1e-05	0.00113	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.1e-05	0.00113	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.09e-05	0.00112	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	1.09e-05	0.00112	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.05e-05	0.00108	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.01e-05	0.00104	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1e-05	0.00103	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.99e-06	0.00102	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	9.2e-06	0.000943	CbGpPWpGaD
Molindone—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.12e-06	0.000934	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.84e-06	0.000906	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.82e-06	0.000904	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.78e-06	0.000899	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.68e-06	0.000889	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	8.65e-06	0.000886	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.63e-06	0.000884	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.59e-06	0.00088	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.19e-06	0.000839	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.89e-06	0.000809	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.76e-06	0.000795	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.63e-06	0.000782	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.59e-06	0.000778	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.54e-06	0.000773	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.51e-06	0.00077	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.42e-06	0.00076	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.38e-06	0.000756	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	7.28e-06	0.000746	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.19e-06	0.000737	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.17e-06	0.000735	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.07e-06	0.000725	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	7.06e-06	0.000724	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.04e-06	0.000722	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.03e-06	0.000721	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.95e-06	0.000712	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	6.93e-06	0.00071	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.75e-06	0.000692	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.6e-06	0.000676	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.49e-06	0.000665	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.45e-06	0.000661	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.43e-06	0.000659	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.9e-06	0.000605	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.57e-06	0.000571	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	5.57e-06	0.00057	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	5.32e-06	0.000546	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.31e-06	0.000544	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.25e-06	0.000538	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.22e-06	0.000535	CbGpPWpGaD
Molindone—HTR7—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.1e-06	0.000523	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.05e-06	0.000518	CbGpPWpGaD
Molindone—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	4.7e-06	0.000482	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.66e-06	0.000478	CbGpPWpGaD
Molindone—HTR7—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.63e-06	0.000475	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.59e-06	0.00047	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.58e-06	0.00047	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.57e-06	0.000468	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.51e-06	0.000462	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.49e-06	0.00046	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.24e-06	0.000434	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.18e-06	0.000428	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.13e-06	0.000423	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.1e-06	0.00042	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.95e-06	0.000404	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.89e-06	0.000398	CbGpPWpGaD
Molindone—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.78e-06	0.000387	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.74e-06	0.000384	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.62e-06	0.000371	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.56e-06	0.000365	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.54e-06	0.000363	CbGpPWpGaD
Molindone—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.43e-06	0.000352	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.41e-06	0.00035	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.36e-06	0.000344	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.34e-06	0.000342	CbGpPWpGaD
Molindone—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.32e-06	0.00034	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.29e-06	0.000337	CbGpPWpGaD
Molindone—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.27e-06	0.000335	CbGpPWpGaD
Molindone—CHRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.25e-06	0.000333	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.24e-06	0.000332	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.24e-06	0.000332	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.23e-06	0.000332	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.22e-06	0.00033	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.14e-06	0.000322	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.1e-06	0.000318	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.06e-06	0.000313	CbGpPWpGaD
Molindone—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.01e-06	0.000309	CbGpPWpGaD
Molindone—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.97e-06	0.000304	CbGpPWpGaD
Molindone—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.97e-06	0.000304	CbGpPWpGaD
Molindone—CHRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.95e-06	0.000302	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.94e-06	0.000302	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.92e-06	0.0003	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.76e-06	0.000282	CbGpPWpGaD
Molindone—HTR7—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.74e-06	0.00028	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.71e-06	0.000278	CbGpPWpGaD
Molindone—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.7e-06	0.000276	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.7e-06	0.000276	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.57e-06	0.000263	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.53e-06	0.000259	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.51e-06	0.000257	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.47e-06	0.000253	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.4e-06	0.000246	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.3e-06	0.000235	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.3e-06	0.000235	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.11e-06	0.000216	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.07e-06	0.000213	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.06e-06	0.000211	CbGpPWpGaD
Molindone—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.03e-06	0.000208	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.02e-06	0.000207	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.98e-06	0.000203	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.97e-06	0.000202	CbGpPWpGaD
Molindone—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.91e-06	0.000195	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.89e-06	0.000193	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.8e-06	0.000185	CbGpPWpGaD
Molindone—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.78e-06	0.000182	CbGpPWpGaD
Molindone—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.75e-06	0.000179	CbGpPWpGaD
Molindone—CHRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.74e-06	0.000179	CbGpPWpGaD
Molindone—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.59e-06	0.000163	CbGpPWpGaD
